BAXTER INTERNATIONAL $72.94

up +1.09


17/5/2013 07:17 PM  |  NYSE : BAX  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
12 Mo. Price Change : 38% - BAX has outperformed the S&P 500 by 12%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Biogen Hemophilia Drug News, Upgrades Lift Stock

    Investors Business Daily

  2. Guru Stocks at 52-Week Highs: CMCSA, DE, CPB, and BAX

    GuruFocus

  3. Celgene, ResMed, Bristol, Biogen Stocks Move On News

    Investors Business Daily

  4. Medical Stock Wrap: Celgene, Bristol, Baxter, Biogen

    Investors Business Daily

  5. Baxter to Buy OBI-1 from Inspiration BioPharma for Upfront Payment ...

    Benzinga

  6. US Stock Futures Mixed After Disappointing Apple Results

    Benzinga

  7. Earnings Scheduled For January 24, 2013

    Benzinga

  8. St. Jude Beats Profit Forecast By Slashing Costs

    Investors Business Daily

  9. Baxter International Inc: Fundamental Stock Research Analysis

    GuruFocus

  10. Medtech Stocks Moving As Conference Makes Waves

    Investors Business Daily

  11. Medtech Stocks Moving As Conference Makes Waves

    Investors Business Daily

  12. Baxter Offers Phase III Data on Prophylaxis Treatment of FEIBA NF

    Benzinga

  13. The Story Behind Little Halozyme's Seemingly Exciting Hookup With ...

    YCharts

  14. ResMed CEO Farrell Not Sleeping Easy With 2013 Here

    Investors Business Daily

  15. Cell Therapy Might Be Poised For A Comeback

    Investors Business Daily

  16. Hemophilia Treatment Could Take A New Leap

    Investors Business Daily

  17. Baxter Presents Phase I/III Data Evaluating Safety, Efficacy of ...

    Benzinga

  18. A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD)

    Benzinga

  19. Bank of America Merrill Lynch Reiterates Buy Rating, $70 PO on ...

    Benzinga

  20. Baxter buys dialysis firm

    Investors Business Daily

  21. Benzinga's M&A Chatter for Tuesday December 4, 2012

    Benzinga

  22. Baxter International Buying Gambro For $4 Billion

    Investors Business Daily

  23. Baxter Reaches $4B Pact to Acquire Sweden's Gambro

    FOXBusiness

  24. Futures Trade Positive, Steady; Qihoo 360, Big Lots In Motion

    Investors Business Daily

  25. Stock Futures Flat Amid Fiscal Caution

    FOXBusiness

  26. Stocks Struggle for Direction

    FOXBusiness

  27. Baxter Acquires Dialysis Product Company Gambro

    Benzinga

  28. Medical Device Makers: Repeal the New Tax!

    FOXBusiness

  29. The Unbridled Truth About Dividends' Contribution to Shareholder ...

    GuruFocus

  30. UPDATE: JP Morgan Reiterates Baxter International at Overweight; ...

    Benzinga

  31. UPDATE: Morgan Stanley Reiterates Baxter International at ...

    Benzinga

  32. UPDATE: Bank of America Raises PT to $70 on Baxter International; ...

    Benzinga

  33. Baxter seen mulling $4 bil bid

    Investors Business Daily

  34. Baxter Stock Hits 4-Year High On Buyout Report

    Investors Business Daily

  35. Benzinga's Top Initiations

    Benzinga

  36. Top 4 Large-Cap Stocks In The Medical Instruments & Supplies ...

    Benzinga

  37. Best & Worst ETFs and Mutual Funds: Large Cap Value Style

    Benzinga

  38. Baxter International Inc. Reports Operating Results (10-Q)

    GuruFocus

  39. Biogen Hemophilia Trial Meets Goals, But Stock Falls

    Investors Business Daily

  40. Diamond Hill Capital Comments on Baxter International

    GuruFocus

  41. NuPathe Announces Closing of $28 Million Private Placement and ...

    Benzinga

  42. Baxter sales light, EPS in line

    Investors Business Daily

  43. Baxter Q3 Sales Light; Medtech Stocks Fall

    Investors Business Daily

  44. US Stock Futures Flat; Morgan Stanley Earnings, Jobless Claims ...

    Benzinga

  45. Earnings Scheduled For October 18, 2012

    Benzinga

  46. Top 4 Large-Cap Stocks In The Medical Instruments & Supplies ...

    Benzinga

  47. Edwards Buys Dutch Medtech Firm; Stock Recovering

    Investors Business Daily

  48. Baxter sees 7%-9% growth

    Investors Business Daily

  49. Baxter Guides Boosting EPS 7-9% on CAGR Over 5-Year Plan

    Benzinga

  50. UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on ...

    Benzinga

  51. Baxter Appoints Two New Directors to Its Board

    Benzinga

  52. Biogen Reports Good Results For Hemophilia Drug

    Investors Business Daily

  53. Highs & Lows: Baxter International, Google, Jazz Pharmaceuticals, ...

    By SchaeffersResearch

  54. Medtronic Inc. (MDT) Dividend Stock Analysis

    GuruFocus

  55. UPDATE: BMO Capital Markets Initiates Coverage on Baxter ...

    Benzinga

  56. Onconova May Receive up to $515M in Milestones

    Benzinga

  57. Baxter International Keeps Lifting Dividend

    Investors Business Daily

  58. Covidien Stock Dips As Product Recall Nips Guidance

    Investors Business Daily

  59. Pimco's Kashkari Gives 3 Favorite Stock Ideas

    GuruFocus

  60. John Hussman Reports Target, Coinstar, Baxter and CF Industries as ...

    GuruFocus

  61. Baxter International Inc. Reports Operating Results (10-Q)

    GuruFocus

  62. This Major Oil Producer Just Increased Its Dividend 40%

    GuruFocus

  63. The Best Stocks With Dividend Growth From Last Week (July 23 - ...

    GuruFocus

  64. Looking for Olympic Winners, in the Stock Market

    FOXBusiness

  65. Apple (AAPL) Pulls Tech Stocks Lower as Market Tries to Rebound

    At Market Intelligence Center

  66. Baxter Raises Dividend 34% and Announces New $2B Share Repurchase ...

    Benzinga

  67. UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on Baxter ...

    Benzinga

  68. Baxter profit rises almost 5%

    Investors Business Daily

  69. Baxter Tops Q2 Estimates, Guides Q3 Profit Low

    Investors Business Daily

  70. Baxter International Inc 2Q Results: Postgame Scorecard

    FOXBusiness

  71. Financial Breakfast: Morning News Summary for July 19, 2012

    Benzinga

  72. Earnings Scheduled For July 19

    Benzinga

  73. UnitedHealth's Q2 Earnings Sign Of Insurers Health

    Investors Business Daily

  74. Baxter International (BAX) Trading Up 2.4% with Above Average ...

    At Market Intelligence Center

  75. Winning CEOs State Values And Live By Them

    Investors Business Daily

  76. Stocks Rally After Disappointing Economic Data Raises Hopes for ...

    At Market Intelligence Center

  77. Baxter Announces ADVATE Approval in China for the Treatment of ...

    Benzinga

  78. Stocks Narrowly Mixed as Earnings and Data Roll in with Mattel ...

    At Market Intelligence Center

  79. Baxter

    at IBD

  80. Baxter International (BAX) Loses 5.4% on FDA Request for ...

    At Market Intelligence Center

  81. Halozyme Therapeutics (HALO) Loses 20.9% After FDA Asks For More ...

    At Market Intelligence Center

  82. Baxter, Halozyme Stocks Plunge On FDA Delay

    at IBD

  83. Stocks Lower on Data With Sears (SHLD) and Toll Brothers (TOL) on ...

    At Market Intelligence Center

  84. Halozyme Q4 results fall short

    at IBD

  85. UPDATE: Dougherty & Company Raises PT on Baxter International to $56

    at Benzinga

  86. Baxter Receives Marketing Authorization in European Union for ...

    at Benzinga

  87. Stocks Modestly Higher With Nokia (NOK) and Oracle (ORCL) on the Move

    At Market Intelligence Center

  88. Financial Breakfast: Morning News Summary for February 24, 2012

    at Benzinga

  89. Baxter International Inc. Reports Operating Results (10-K)

    at GuruFocus

  90. Stocks Flat LinkedIn (LNKD) and Kimco Realty (KIM) on the Move

    At Market Intelligence Center

  91. Piper Jaffray Lowers PT on Baxter International to $65

    at Benzinga

  92. Baxter Int'l

    at IBD

  93. Morgan Keegan Reports Baxter to Initiate Second PIII Alzheimer's ...

    at Benzinga

  94. Apple, Top Manufacturers Lead S&P 100 Earnings Due

    at IBD

  95. Biosimilar Drug Era Dawns

    at IBD

  96. Biotechs Cut Biosimilar Deals As FDA Carves Path

    at IBD

  97. Stocks Bounce Off of Midday Lows with Research in Motion (RIMM) ...

    At Market Intelligence Center

  98. Feltl and Company Downgrades Synovis Life Technologies to Sell

    at Benzinga

  99. JP Morgan Reiterates Overweight, $60 Target on Baxter International

    at Benzinga

  100. Baxter Initiates Phase I Clinical Trial of Longer-Acting ...

    at Benzinga
People viewing BAX also viewed: , , , , , ,
Marketplace
Trading Center